Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Resonant Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Resonant Therapeutics

Resonant Therapeutics

Resonant Therapeutics: A scalable platform accelerating tumor therapy & goal discovery.

HQ
Houston, TX, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Resonant Therapeutics, founded with the mission to revolutionize cancer treatment, focuses on developing a scalable tumor microenvironment platform that accelerates the discovery of therapeutic targets. The company offers diverse antibody drugs aimed at novel, highly selective tumor targets, enhancing the precision and effectiveness of cancer therapies. Resonant's innovative approach aims to transform the oncology market by providing advanced solutions for tumor therapy and goal discovery.

Notable collaborations include partnerships with Janssen and Retrogenix, highlighting the company's strategic alliances to identify and target anti-tumor antibodies. These partnerships have propelled Resonant Therapeutics to achieve significant advancements in their research and development efforts. The impact of their work is evident in the accelerated pace of therapeutic discoveries, positioning Resonant as a key player in the field of oncology.

Resonant Therapeutics - Similar Companies

OncoResponse logo

OncoResponse

OmniAb logo

OmniAb

omniab.com

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

Resilience Therapeutics logo

Resilience Therapeutics

Crossbow Therapeutics logo

Crossbow Therapeutics

crossbowtx.com

GV20 Therapeutics logo

GV20 Therapeutics

gv20tx.com

Ensem Therapeutics logo

Ensem Therapeutics

ensemtx.com

Rondo Therapeutics logo

Rondo Therapeutics

rondotx.com

Mersana Therapeutics logo

Mersana Therapeutics

mersana.com

Parthenon Therapeutics logo

Parthenon Therapeutics

parthenontx.com

Alloy Therapeutics logo

Alloy Therapeutics

alloytx.com

Meditope Biosciences logo

Meditope Biosciences

meditope.com

Amberstone Biosciences logo

Amberstone Biosciences

amberstonebio.com

Angarus Therapeutics logo

Angarus Therapeutics

angarustx.com

Aarvik Therapeutics logo

Aarvik Therapeutics

aarviktx.com

Resonant Therapeutics - Quick Facts

Who are Resonant Therapeutics' competitors?

Companies similar to Resonant Therapeutics include OncoResponse, OmniAb, PanTher Therapeutics and Resilience Therapeutics.

When was Resonant Therapeutics founded?

Resonant Therapeutics was founded in 2014.

Where is Resonant Therapeutics' headquarters located?

Resonant Therapeutics' headquarters is located in Houston, TX, US.

When was Resonant Therapeutics' last funding round?

Resonant Therapeutics' most recent funding round was for $2.5M (USD) in October 2021.

How much has Resonant Therapeutics raised to-date?

As of Oct 28, 2021, Resonant Therapeutics has raised a total of $4.5M (USD).

How many employees does Resonant Therapeutics have?

Resonant Therapeutics has 5 employees as of Feb 5, 2024.

Resonant Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Antibody Drugs
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified